Pfizer’s “Fine” Example
September 3, 2009
Pfizer, the world’s largest drug maker, was fined $2.3 billion for promoting drugs for uses that they were not approved for. In the past decade over $11 billion in fines has been assessed against the U.S. drug industry for similar offenses. This is the fourth time that Pfizer has been reprimanded. However, this record fine is designed to be a warning to all drug manufacturers who regularly see these fines as the cost of doing business. One example of their deception was to market Bextra for acute pain and surgical pain in doses above the approved maximum when it was only approved for arthritis. As a way of promoting the use of the drugs, Pfizer gave away trips, golf junkets, massages, and other perks to ply doctors into prescribing the drugs. click here for limerick
Enter your email address below to